Clinical Trial Update: A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-64041575 in Adult Participants With Various Degrees of Renal Function [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate how different levels of renal function affect the pharmacokinetics of JNJ-64041575 in adult participants. The study status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• JNJ-64041575 (JNJ-64041575)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED